641 related articles for article (PubMed ID: 17111392)
1. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
[TBL] [Abstract][Full Text] [Related]
2. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
3. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
4. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
J Clin Oncol; 2005 Sep; 23(25):6149-56. PubMed ID: 16135481
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
Schneider BP; Kesler KA; Brooks JA; Yiannoutsos C; Einhorn LH
J Clin Oncol; 2004 Apr; 22(7):1195-200. PubMed ID: 15051766
[TBL] [Abstract][Full Text] [Related]
6. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.
Kang CH; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Feb; 85(2):379-84. PubMed ID: 18222229
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
9. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
Spiess PE; Brown GA; Pisters LL; Liu P; Tu SM; Evans JG; Kamat AM; Black P; Tannir NM
Cancer; 2006 Oct; 107(7):1503-10. PubMed ID: 16944534
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
11. Testicular germ cell tumors, an update. Results of the German cooperative studies 1982-1997.
Haas RJ; Schmidt P; Göbel U; Harms D
Klin Padiatr; 1999; 211(4):300-4. PubMed ID: 10472566
[TBL] [Abstract][Full Text] [Related]
12. Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.
Hautkappe AL; Lu M; Mueller H; Bex A; Harstrick A; Roggendorf M; Ruebben H
Cancer Res; 2000 Jun; 60(12):3170-4. PubMed ID: 10866307
[TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
Spiess PE; Brown GA; Liu P; Tannir NM; Tu SM; Evans JG; Czerniak B; Kamat AM; Pisters LL
Cancer; 2006 Oct; 107(7):1483-90. PubMed ID: 16944541
[TBL] [Abstract][Full Text] [Related]
14. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary metastasectomy following chemotherapy in patients with testicular tumors: experience in 52 patients.
Pfannschmidt J; Zabeck H; Muley T; Dienemann H; Hoffmann H
Thorac Cardiovasc Surg; 2006 Oct; 54(7):484-8. PubMed ID: 17089317
[TBL] [Abstract][Full Text] [Related]
16. Serum markers in germ cell neoplasms.
Bartlett NL; Freiha FS; Torti FM
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1245-60. PubMed ID: 1723408
[TBL] [Abstract][Full Text] [Related]
17. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment.
Murugaesu N; Schmid P; Dancey G; Agarwal R; Holden L; McNeish I; Savage PM; Newlands ES; Rustin GJ; Seckl MJ
J Clin Oncol; 2006 Oct; 24(30):4862-6. PubMed ID: 17050871
[TBL] [Abstract][Full Text] [Related]
18. Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
Che Y; Buddensieck C; Albers P; Lusch A; Winter C; Siemer RG; Hiester A
J Urol; 2022 Mar; 207(3):617-626. PubMed ID: 34694152
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
[TBL] [Abstract][Full Text] [Related]
20. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
